title: Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
abstract: OBJECTIVE
  The aim of this study was to evaluate and to compare clinical and radiographic outcomes of 4 materials (formocresol, mineral trioxide aggregate (MTA), Portland cement and enamel matrix derivative) using in primary teeth pulpotomies.
  
  
  METHODS
  Sixty-five patients aged 5-9 years (32 female, 33 male) were included in this study. A total of 140 primary first and second molars with deep caries were treated with pulpotomy. All teeth were then restored with stainless steel crowns. The treated teeth were evaluated clinically and radiographically at 3, 6, 12, 18 and 24 months.
  
  
  RESULTS
  At 24 months, the clinical success rates of formocresol, MTA, Portland cement, and enamel matrix derivative were 96.9%, 100%, 93.9%, and 93.3%, respectively. The corresponding radiographic success rates were 84.4%, 93.9%, 86.7% and 78.1%, respectively.
  
  
  CONCLUSIONS
  Although there were no statistically significant differences in clinical and radiographic success rates among the 4 groups, MTA appears to be superior to formocresol, Portland cement, and enamel matrix derivative as a pulpotomy agent in primary teeth.
authors.affiliation: From Gulhane Medical Academy, Pediatric Dentistry Department, Ankara, Turkey.
authors.forename: Ceren
authors.initials: C
authors.lastname: Yildirim
authors.affiliation: From Gulhane Medical Academy, Pediatric Dentistry Department, Ankara, Turkey.
authors.forename: Feridun
authors.initials: F
authors.lastname: Basak
authors.affiliation: From Gulhane Medical Academy, Pediatric Dentistry Department, Ankara, Turkey.
authors.forename: Ozlem Marti
authors.initials: OM
authors.lastname: Akgun
authors.affiliation: From Gulhane Medical Academy, Pediatric Dentistry Department, Ankara, Turkey.
authors.forename: Gunseli Guven
authors.initials: GG
authors.lastname: Polat
authors.affiliation: From Gulhane Medical Academy, Pediatric Dentistry Department, Ankara, Turkey.
authors.forename: Ceyhan
authors.initials: C
authors.lastname: Altun
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use; D017610:Calcium Compounds / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003442:Crowns; D003731:Dental Caries / Q000628:therapy; D003746:Dental Enamel Proteins / Q000627:therapeutic use; D003789:Dental Pulp Exposure / Q000628:therapy; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D005566:Formocresols / Q000627:therapeutic use; D005899:Glass Ionomer Cements / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008963:Molar / Q000000981:diagnostic imaging / Q000187:drug effects*; D010087:Oxides / Q000627:therapeutic use; D010486:Periapical Tissue / Q000000981:diagnostic imaging; D057872:Pulp Capping and Pulpectomy Agents / Q000627:therapeutic use*; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D017640:Silicates / Q000627:therapeutic use; D013193:Stainless Steel / Q000737:chemistry; D014094:Tooth, Deciduous / Q000000981:diagnostic imaging / Q000187:drug effects*; D016896:Treatment Outcome; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D003746:Dental Enamel Proteins; D004338:Drug Combinations; D005566:Formocresols; D005899:Glass Ionomer Cements; D010087:Oxides; D057872:Pulp Capping and Pulpectomy Agents; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C109069:enamel matrix proteins; C086631:mineral trioxide aggregate; D013193:Stainless Steel; C031025:formocresol; C031293:calcium silicate
keywords: Enamel matrix derivative; Formocresol; Mineral trioxide aggregate; Portland cement; Pulpotomy